What is Springtide Child Development?
Springtide Child Development, based in New York City, NY, operates as a multi-site practice dedicated to treating children with developmental disabilities. The company's focus on specialized care positions it as a key player in a critical segment of the healthcare market. The recent enterprise-level funding suggests a strategic push towards scaling its operations and expanding its reach within this specialized sector.
How much funding has Springtide Child Development raised?
Springtide Child Development has raised a total of $18.1M across 1 funding round:
Series A
$18.1M
Series A (2020): $18.1M with participation from Deerfield Communications Inc and Optum Ventures
Key Investors in Springtide Child Development
Deerfield Communications Inc
Deerfield Communications Inc is an investor in this funding round. Further details on their specific investment focus are not publicly available.
Optum Ventures
Optum Ventures is a venture capital firm focused on investing in early-stage companies poised to disrupt the healthcare industry, aiming to improve healthcare for everyone.
What's next for Springtide Child Development?
The substantial enterprise-level funding, particularly the recent strategic investment, indicates that Springtide Child Development is likely entering a phase of significant expansion and operational enhancement. This capital infusion is expected to fuel growth initiatives, potentially including the establishment of new treatment centers, the enhancement of existing facilities, and the advancement of therapeutic methodologies. The company's trajectory suggests a move towards solidifying its market leadership and increasing its impact on pediatric developmental care.
See full Springtide Child Development company page
